We are a team of passionate scientists, doctors and clinicians, driven to fight late stage cancers.
ABOUT ANVIRON
About our company, our mission and our team.
OUR PIPELINE
Overview of our pipeline and our science
LATEST NEWS
Latest news releases and investor packages
COMMUNICATIONS
Get regular updates on our company and pipeline
Our pipeline consists of a promising family of small molecules inhibitors of proteins responsible for unconstrained proliferation signaling and metastasis.
ANV221 for Pancreatic Cancer
A low toxicity, novel product candidate shown to reduce pancreatic cancer tumor size and suppress metastases superior to approved standard of care drugs in vivo models.
